Moreover, to further identify the potential immunotherapy strategy of glioma targeting COL4A factors and HMGA2, immunomodulators associated with COL4A factors and HMGA2 were retrieved from the online database TISIDB (Figure 10; Supplementary Figure S6). Here, HMGA2 is linked to glioma.